Biological, Preclinical and Clinical Characteristics of Inhibitors of Vascular Endothelial Growth Factors
出版年份 2012 全文链接
标题
Biological, Preclinical and Clinical Characteristics of Inhibitors of Vascular Endothelial Growth Factors
作者
关键词
-
出版物
OPHTHALMOLOGICA
Volume 227, Issue s1, Pages 2-10
出版商
S. Karger AG
发表日期
2012-04-19
DOI
10.1159/000337152
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Comparing protein VEGF inhibitors: In vitro biological studies
- (2011) Lanlan Yu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Preclinical aspects of anti-VEGF agents for the treatment of wet AMD: ranibizumab and bevacizumab
- (2011) C H Meyer et al. EYE
- From the discovery of Vascular Endothelial Growth Factor to the introduction of Avastin in clinical trials - an interview with Napoleone Ferrara
- (2011) Domenico Ribatti INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY
- Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- INTRAOCULAR PHARMACOKINETICS AFTER A SINGLE INTRAVITREAL INJECTION OF 1.5 mg VERSUS 3.0 mg OF BEVACIZUMAB IN HUMANS
- (2011) Carsten H Meyer et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Systemic and Ocular Safety of Intravitreal Anti-VEGF Therapies for Ocular Neovascular Disease
- (2011) Michael Tolentino SURVEY OF OPHTHALMOLOGY
- Concentrations of unbound bevacizumab in the aqueous of untreated fellow eyes after a single intravitreal injection in humans
- (2010) Carsten H. Meyer et al. ACTA OPHTHALMOLOGICA
- Incidence of New Choroidal Neovascularization in Fellow Eyes of Patients Treated in the MARINA and ANCHOR Trials
- (2010) Irene A. Barbazetto et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Risks of Mortality, Myocardial Infarction, Bleeding, and Stroke Associated With Therapies for Age-Related Macular Degeneration
- (2010) Lesley H. Curtis ARCHIVES OF OPHTHALMOLOGY
- Plasma levels of vascular endothelial growth factor and pigment epithelium-derived factor before and after intravitreal injection of bevacizumab
- (2010) K. Matsuyama et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Lack of Therapeutic Effect of Ranibizumab in Fellow Eyes After Intravitreal Administration
- (2010) Maria-Andreea Gamulescu et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Clinical safety of ranibizumab in age-related macular degeneration
- (2009) Ursula Schmidt-Erfurth Expert Opinion On Drug Safety
- Neovascular Age-related Macular Degeneration: Intraocular Cytokines and Growth Factors and the Influence of Therapy with Ranibizumab
- (2009) Marion Funk et al. OPHTHALMOLOGY
- VEGF-B is dispensable for blood vessel growth but critical for their survival, and VEGF-B targeting inhibits pathological angiogenesis
- (2009) F. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Predicted biological activity of intravitreal VEGF Trap
- (2008) M W Stewart et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Clinical pharmacokinetics of bevacizumab in patients with solid tumors
- (2008) Jian-Feng Lu et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Vascular endothelial growth factor in fellow eyes of eyes injected with intravitreal bevacizumab
- (2008) Osamu Sawada et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- VEGF Inhibition and Renal Thrombotic Microangiopathy
- (2008) Vera Eremina et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pharmacokinetics
- (2008) Suk Ho Byeon et al. OPHTHALMOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started